Data / Form D filings / Third Coast Therapeutics, Inc.
Third Coast Therapeutics, Inc.: Form D filings
Third Coast Therapeutics, Inc., a pharmaceuticals company in Evanston, IL, filed 2 Form D notices with the SEC between 2017 and 2018. The latest, on September 24, 2018, reports $35,000 sold of a $600,000 offering to 2 investors.
Find out what Third Coast Therapeutics, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 600 DAVIS STREET, Evanston, IL, 60201
- Phone
- (608) 772-5878
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1706603
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 24, 2018 | New notice | $600,000 | $35,000 | $565,000 | 2 | Sep 18, 2018 | sec.gov |
| Jun 5, 2017 | New notice | $1,200,000 | $50,000 | $1,150,000 | 3 | Feb 23, 2017 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karl Scheidt | Director | |
| Raymond Bergan | Director | |
| Joseph Luminiello | Executive Officer, Director |
Every Form D from the week of Sep 24, 2018 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Third Coast Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.